CD274 and non-small cell lung carcinoma: Overexpression of PD-L1 has been reported in many different tumor types, such as melanoma (40–100%), Non-Small Cell Lung Carcinoma (NSCLC) (35%-95%), Glioblastoma (100%), ovarian cancer (33–80%), and colorectal adenocarcinoma (53%)6.